Skip to Content
Rating as of

Morningstar’s Analysis

Currency in AUD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


No-Moat ALS' Coronavirus-Resistant Fiscal 2021 Earnings as Expected; No Change to AUD 5.50 FVE

Mark Taylor Senior Equity Analyst

Analyst Note

| Mark Taylor |

Our AUD 5.50 fair value estimate for no-moat ALS Limited is unchanged. The materials testing specialist reported a 1.5% decline in underlying fiscal 2021 net profit after tax to AUD 186 million, marginally ahead of our AUD 178 million expectations. We make no material changes to our outlook, including for a 12% increase in underlying fiscal 2022 NPAT to AUD 209 million. ALS paid a higher-than-anticipated fiscal second-half dividend of AUD 14.6 cents against our AUD 12.5 cents target. It brings the full fiscal year to AUD 23.1 cents for a modest 1.9% yield at the current AUD 12.30 share price, franked to 81%. Our fiscal 2022 DPS forecast is little changed at AUD 26 cents, a prospective partially franked yield of 2.1%, again modest.

Read Full Analysis

Company Profile

Business Description

Founded in the 1880s and listing on the ASX in 1952, ALS operates three divisions: commodities, life sciences, and industrial. ALS commodities traditionally generated the majority of underlying earnings, providing geochemistry, metallurgy, inspection and mine site services for the global mining industry. Expansion into environmental, pharmaceutical and food testing areas and commodity price weakness have lessened earnings exposure to commodities.

32 Shand Street, Stafford
Brisbane, QLD, 4053, Australia
T +61 733677900
Sector Industrials
Industry Consulting Services
Most Recent Earnings
Fiscal Year End Mar 31, 2022
Stock Type
Employees 15,638

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.